This is a quickie for you, I came across it and don’t want to write up a full look at the company but I thought some of you would like the teaser solution. The ad’s from Agora Financial’s FDA Trader, which has been touting this “magic calendar” idea of investing in stocks around (mostly) PDUFA […]
Articles
NASH: An All-Too-Common Liver Disease and a Company Aiming to Treat It[ed. note: Gumshoe readers have been delighted with the biotech stock discussion led by one of our readers, who has gone by the name karmaswimswami as he has shared hundreds of useful comments — so we’ve asked him to come on as a formal contributor, he’ll be sharing a column with the Irregulars and talking […]
We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.
More Info
Comments
Post did not include my Title: "New Karim Rahemtulla producr". Now with Oxford Club. Thanks, Martin (Irregular Member)...
FYI, Karim Rahemtulla of Wall Street Daily is out with a ...
Thanks for saving me. I was about to plunk down $400 but decided to check StockGumshoe first. In return, I'd like to re...
Regarding options trading and various options strategies, there is Karim Rahemtulla. He's the options editor for Invest...
Steve MacDonald is a very funny Oxford talk-show man. He did a gig in Ottawa together with Karim Rahemtulla, his straigh...
Several years ago Karim Rahemtulla and his Agora cronies held a seminar--the video of which I have--about selling covere...
I believe Karim Rahemtulla has 3 investment letters based on options ect have any of you tried his services and if so h...